[Medical prescriptions in haemodialysis patients: critical analysis].
OBJECTIVE
The aim of the study is to analyse haemodialysis patients' prescriptions accordance with legal registrations in 64 chronic haemodialysis patients during a one-month follow-up period.


RESULTS
Patients are taking 9.6+/-3 different drugs. A mean of 2.4+/-1.3 prescriptions per patient disagree with the recommended drug use. The directions for use in this specific population are defective in 89%. Moreover, at least one drug-drug interaction is found in 78% of our patients.


CONCLUSIONS
Only 8% of the studied hemodialysis patients benefit from prescriptions in agreement with the legal recordings, as a consequence of the lack of drug studies in this particular population. Therefore, clinicians have to rely on their own experience to establish their prescriptions, which can involve their responsibility in case of litigation. Furthermore, the frequency of drug-drug interactions in these polymedicated patients implies that a close pharmaceutical follow-up should be implemented.
Riemer
Evelyne
E
Service de pharmacie, centre hospitalier de Haguenau, France.
Werling
Estelle
E
Kribs
Marc
M
Hamman De Compte
Annick
A
Dimitrov
Yves
Y
D000368:Aged; D003430:Cross-Sectional Studies; D004347:Drug Interactions; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D004358:Drug Therapy / Q000592:standards; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis